To further evaluate whether FZD7 is a prognostic marker for early or late ESCC, we studied the association of FZD7 overexpression with the survival rate in ESCC patients stratified by tumor staging. The gene discussed is FZD7; the disease is esophageal squamous cell carcinoma.